Navigation Links
Alexion to Present at the William Blair 28th Annual Growth Stock Conference
Date:6/13/2008

CHESHIRE, Conn., June 13 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Senior Vice President and Chief Financial Officer of Alexion Pharmaceuticals, will present at the William Blair 28th Annual Growth Stock Conference in Chicago at 9:10 a.m., local time (10:10 a.m., eastern) on Thursday, June 19, 2008.

An audio webcast of Mr. Sinha's remarks will be available live. You can access the webcast at: http://www.alexionpharm.com. An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.

[ALXN-G]


'/>"/>
SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Notice of Time Change for Alexions Presentation at the Bank of America 2008 Health Care Conference
2. Alexion Reports First Quarter 2008 Results
3. Alexion Reports Fourth Quarter and Full Year 2007 Results
4. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
5. Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast
6. Alexion to Present at Bear Stearns Healthcare Conference
7. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
8. Genaera Corporation to Present at BIO Business Forum
9. Oncolytics Biotech Inc. to Present at BIO 2008 International Convention
10. Senesco Technologies to Present at BIO 2008 Business Forum
11. BioMS Medical to present at 2008 BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... phase I/II dose escalation and expansion clinical trial for its lead drug candidate, ... The purpose of the trial was to determine the safety, antitumor activity, and ...
(Date:12/7/2016)... Dec. 7, 2016 Neogen Corporation (NASDAQ: ... Dan Kephart as its chief science officer ... assume his responsibilities at Neogen effective Jan. 1. ... for the agribusiness unit of Thermo Fisher Scientific, as ... Life Technologies. His extensive industry experience also includes the ...
(Date:12/7/2016)... OTTAWA, Ontario , Dec. 7, 2016 /PRNewswire/ ... partnership with General Atomics (GA), welcome today,s award ... National Nuclear Security Administration (NNSA) of the Phase ... its project with Nordion and the University of ... Phase II funding will support the establishment of ...
Breaking Biology Technology:
(Date:6/21/2016)... Columbia , June 21, 2016 ... to the new role of principal product architect ... named the director of customer development. Both will ... chief technical officer. The moves reflect NuData,s strategic ... in response to high customer demand and customer ...
(Date:6/16/2016)... SAN FRANCISCO , June 16, 2016 /PRNewswire/ ... Market size is expected to reach USD ... report by Grand View Research, Inc. Technological proliferation ... and banking applications are expected to drive the ... ) , The development of ...
(Date:6/9/2016)... control systems is proud to announce the introduction of fingerprint attendance control software, allowing ... are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
Breaking Biology News(10 mins):